Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles

Author(s):  Voudrie Mark A, Alexander Bridget, Allen D Brett

Issue:  May/Jun 2011 - Volume 15, Number 3
View All Articles in Issue

Page(s):  255-258

Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Page 1
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Page 2
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Page 3
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Page 4

Download in electronic PDF format for $75

Abstract:  Verapamil hydrochloride is widely prescribed to treat multiple cardiovascular diseases. There are a number of generic manufacturers of verapamil tablets and injectables. The need for other administration options for patients who cannot take tablets has led compounding pharmacies to seek other alternatives, namely, oral solutions and suspensions. The stability of these compounded verapamil oral liquid preparations is a concern to anyone making them. The objective of this study was to determine the stability of verapamil hydrochloride in SyrSpend SF in comparison to stability of verapamil hydrochloride in Ora-Sweet SF:Ora-Plus (1:1). The two samples were compounded in 50-mL batches and stored in amber 60-mL plastic prescription bottles at United States Pharmacopeia refrigerated conditions. Five replicates at each pre-defined time point were assayed by a stability-indicating high performance liquid chromatographic method with an end date of 60 days. No degradation peaks were seen in the chromatograms for either preparation at any time point and the recovery of verapamil hydrochloride was within 90% to 110% of the initial concentration for all replicates. Verapamil hydrochloride is stable in amber plastic prescription bottles for 60 days when refrigerated for both SyrSpend SF and Ora-Sweet SF:Ora-Plus (1:1).

Related Keywords: Mark A. Voudrie II, MS, PMP, Bridget Alexander, BS, CAPM, D. Brett Allen, BS, verapamil hydrochloride, calcium channel blocker, oral suspensions, syrups, suspending vehicles, stability

Related Categories: EXCIPIENTS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, CARDIOLOGY, STORAGE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles
Voudrie Mark A
, Alexander Bridget, Allen D Brett
May/Jun 2011
Pg. 255-258

Stability of Propranolol Hydrochloride in SyrSpend SF
Geiger Christine M
, Voudrie Mark A II, Sorenson Bridget
Nov/Dec 2012
Pg. 513-515

Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Voudrie Mark A II
, Allen D Brett
Jan/Feb 2010
Pg. 82-85

Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Sep/Oct 2019
Pg. 413

Stability of Gabapentin in SyrSpend SF
Sorenson Bridget
, Voudrie Mark A II, Gehrig Dan
Jul/Aug 2012
Pg. 347-349

Stability of Ursodiol in SyrSpend SF Cherry Flavored
Geiger Christine M
, Voudrie Mark A II, Sorenson Bridget
Nov/Dec 2012
Pg. 510-512

Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Geiger Christine M
, Sorenson Bridget, Whaley Paul
Sep/Oct 2015
Pg. 420-427

Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Allen Loyd V Jr
Nov/Dec 2019
Pg. 494

Verapamil Hydrochloride 2.5-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 153

Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)
Whaley Paul A
, Voudrie Mark A II, Sorenson Bridget
Mar/Apr 2012
Pg. 164-166

Oral Liquid Vehicles, Featured Excipient:
Allen Loyd V Jr
Jan/Feb 2001
Pg. 65-67

Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Geiger Christine M
, Sorenson Bridget, Whaley Paul A
Jul/Aug 2013
Pg. 344-346

Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson
, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Nov/Dec 2018
Pg. 516-526

Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 493

Stability of Captopril in SyrSPend SF
Geiger Christine M
, Sorenson Bridget, Whaley Paul A
Jul/Aug 2013
Pg. 336-338

Stability of Vancomycin in SyrSpend SF
Whaley Paul A
, Voudrie Mark A II
Mar/Apr 2012
Pg. 167-169

Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S
, Thyangarajapuram N
Sep/Oct 2003
Pg. 389-393

Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson
, Loures da Silva Sharlene, Neves Cunha Carolina, de Oliveira Ferreira Anderson, Anagnostou Korina, Dijkers Eli
May/Jun 2020
Pg. 252-262

Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II
Zhang Yanping
, Xu Quanyun, Trissel Lawrence A, Baker Mary B
Sep/Oct 1999
Pg. 415-420

Stability of Prednisone in Oral Mix Suspending Vehicle
Friciu Mihaela
, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim
Jul/Aug 2015
Pg. 337-339

Return to Top